文献速递消化内镜消化道肿瘤与早癌

使用蓝激光成像的新型内镜系统对结直肠肿瘤性病变检出能力的研究:一项多中心随机对照试验

Detectability of colorectal neoplastic lesions using a novel endoscopic system with blue laser imaging: a multicenter randomized controlled trial.
PubMed 文献 · Gastrointest Endosc · 2017-01-29

这项多中心随机对照试验将≥40岁患者随机分为白光成像(WLI)组和蓝激光成像(BLI)亮模式组,评估BLI对结直肠肿瘤性病变的检出效果。结果显示BLI组每患者平均腺瘤检出数显著高于WLI组(1.27±1.73 vs 1.01±1.36,P=.008),每患者平均息肉数也显著更高(1.84±2.09 vs 1.43±1.64,P=.001),但腺瘤检出率无显著差异,且BLI组观察时间显著更长(9.48分钟 vs 8.42分钟,P<.001)。

要点

  • BLI组每患者平均腺瘤检出数显著高于WLI组(1.27±1.73 vs 1.01±1.36,P=.008)。
  • BLI组腺瘤检出率较WLI组无显著差异。
  • BLI组观察时间显著长于WLI组(9.48分钟 vs 8.42分钟,P<.001)。

核心结论

  • 与白光成像相比,采用蓝激光成像的新开发系统可提高腺瘤性病变的检出。

研究设计与样本

  • 多中心随机对照试验,纳入8家机构中年龄≥40岁的患者。
  • 患者随机分为白光成像组(WLI组,使用传统氙灯光源,474例)和蓝激光成像亮模式组(BLI组,使用激光光源,489例)。
  • 所有检出病变均切除或活检行组织病理学分析,主要结局为每操作每患者平均腺瘤检出数(MAP)。

主要发现

  • BLI组每患者平均腺瘤检出数显著高于WLI组(均值±标准差:WLI 1.01±1.36,BLI 1.27±1.73;P=.008)。
  • BLI组腺瘤检出率较WLI组无显著升高。
  • BLI组观察时间显著长于WLI组(BLI 9.48分钟 vs WLI 8.42分钟;P<.001)。
  • BLI组每患者平均息肉数显著高于WLI组(WLI 1.43±1.64,BLI 1.84±2.09;P=.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Most studies have not reported an improvement in the detection of adenomas with the use of image-enhanced colonoscopy methods, possibly because of the darkness of the images. To overcome this limitation, a new-generation endoscopic system has been developed. This system has 2 blue-laser imaging (BLI) observation modes. The BLI observation was set to BLI-bright mode to detect lesions. We aimed to evaluate the efficacy of BLI in detecting lesions. METHODS: This study was designed as a randomized controlled trial with participants from 8 institutions. We enrolled patients aged ≥40 years. The participants were randomly assigned to 2 groups: observation by using white-light imaging (WLI) with a conventional xenon light source (WLI group) or observation by using BLI-bright mode with a laser light source (BLI group). All of the detected lesions were resected or had a biopsy taken for histopathologic analysis. The primary outcome was the mean number of adenomas per patient (MAP) that were detected per procedure. RESULTS: The WLI and BLI groups consisted of 474 and 489 patients, respectively. The MAP was significantly higher in the BLI group than in the WLI group (mean ± standard deviation [SD] WLI 1.01 ± 1.36, BLI 1.27 ± 1.73; P = .008). Adenoma detection rate in the BLI group was not significantly higher than in the WLI group. Observation times differed significantly, with BLI (9.48 minutes) being longer than WLI (8.42; P < .001). The mean (± SD) number of polyps per patient was significantly higher in the BLI group compared with the WLI group (WLI 1.43 ± 1.64, BLI 1.84 ± 2.09; P = .001). CONCLUSIONS: A newly developed system that uses BLI improves the detection of adenomatous lesions compared with WLI. (Clinical trial registration number: UMIN 000014555.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Ikematsu H, Sakamoto T, Togashi K, et al. Detectability of colorectal neoplastic lesions using a novel endoscopic system with blue laser imaging: a multicenter randomized controlled trial. Gastrointest Endosc. 2017. PMID: 28147226. doi:10.1016/j.gie.2017.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。